Association of Prescription Co-Payment With Adherence to GLP-1 Receptor Agonist and SGLT2 Inhibitor Therapies in Patients With Heart Failure and Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes
JAMA Netw Open 2023 Jun 01;6(6)e2316290, UR Essien, B Singh, G Swabe, AE Johnson, LA Eberly, RK Wadhera, K Breathett, M Vaduganathan, JW MagnaniFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.